Catalysts for GlaxoSmithKline LLC
412 tracked
Feb 22, 2019
approval
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Feb 22, 2019
approval
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Jul 23, 2018
approval
LAMICTAL XR (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Jul 23, 2018
approval
LAMICTAL CD (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Jul 23, 2018
approval
LAMICTAL (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Jul 23, 2018
approval
LAMICTAL ODT (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Jul 17, 2018
approval
IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approval
SUMATRIPTAN SUCCINATE
→
Jun 27, 2018
approval
LAMICTAL XR (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Jun 27, 2018
approval
LAMICTAL CD (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Jun 27, 2018
approval
LAMICTAL (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Jun 27, 2018
approval
LAMICTAL ODT (LAMOTRIGINE) — FDA approval
LAMOTRIGINE
→
Dec 14, 2017
approval
IMITREX (SUMATRIPTAN SUCCINATE) — FDA approval
SUMATRIPTAN SUCCINATE
→
Dec 14, 2017
approval
IMITREX (SUMATRIPTAN) — FDA approval
SUMATRIPTAN SUCCINATE
→
Dec 14, 2017
approval
IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approval
SUMATRIPTAN SUCCINATE
→
Oct 15, 2017
approval
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Aug 23, 2017
approval
FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approval
GlaxoSmithKline LLC
→
Aug 11, 2017
approval
WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approval
BUPROPION HYDROCHLORIDE
→
Aug 11, 2017
approval
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approval
BUPROPION HYDROCHLORIDE
→
May 10, 2017
approval
WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approval
BUPROPION HYDROCHLORIDE
→
May 10, 2017
approval
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approval
BUPROPION HYDROCHLORIDE
→
May 4, 2017
approval
WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approval
BUPROPION HYDROCHLORIDE
→
May 4, 2017
approval
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approval
BUPROPION HYDROCHLORIDE
→
Apr 5, 2017
approval
FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approval
GlaxoSmithKline LLC
→
Aug 2, 2016
approval
FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approval
GlaxoSmithKline LLC
→
Apr 25, 2016
approval
WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approval
BUPROPION HYDROCHLORIDE
→
Apr 25, 2016
approval
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approval
BUPROPION HYDROCHLORIDE
→
Mar 25, 2016
approval
IMITREX (SUMATRIPTAN) — FDA approval
SUMATRIPTAN SUCCINATE
→
Nov 19, 2015
approval
IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approval
SUMATRIPTAN SUCCINATE
→
Jun 11, 2015
approval
IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approval
SUMATRIPTAN SUCCINATE
→
Jun 4, 2015
approval
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→